The case study unveils the likely mechanism of a novel stop-loss DAX1 variant preceding the prolonged
precocious puberty in the
adrenal hypoplasia congenital (AHC) boy. A boy aged five years and nine months initially examined for the
primary adrenal insufficiency symptoms. Next-generation sequencing confirmed the X-linked inheritance of a novel stop-loss DAX1 variant: c.1411T>C/p.Ter471Gln associated with AHC in the patient. The patient was subjected to a brief clinical follow-up from 11 to 15.1 years of age. The effect of the mutant-DAX1 variant (p.Ter471Gln) on DAX1-steroidogenic factor 1 (SF1) (
protein-
protein) interaction was studied by
protein-
protein docking using the ClusPro-online tool. At 5.9 yrs of age, the patient exhibited
precocious puberty with the secondary sexual characteristics of Tanner 2 stage (of 9-14 yrs of age). The patient showed
primary adrenal insufficiency with diminished
cortisol concentrations at blood serum (25 ng/ml) and urine (3.55 μg/24 h) levels. Upon steroidal exposure, the patient showed normalized serum
cortisol levels of 45-61 ng/ml. However, the
precocious puberty got prolonged with the increased penis length of 8.5 cm and the bone age of 18 yrs old during the follow-up. The patient showed increased basal serum
adrenocorticotropic hormone (110->2000 pg/ml) and
follicle-stimulating hormone (18.4-22.3 mIU/ml) concentrations. Following an elevated hypothalamic-pituitary-gonadal axis activity witnessed upon gonarellin stimulation.
Protein-
protein docking confirmed a weaker interaction between the mutant-DAX1 (p.Ter471Gln)
protein and the wild-SF1
protein. Overall, we hypothesize the weakened mutant-DAX1-SF1 (
protein-
protein) interaction could govern the prolonged
precocious puberty augmented with the elevated hypothalamic-pituitary-gonadal/adrenal axis responses via SF1-induced neuronal
nitric oxide synthetase activation in the patient.